Michael Okunewitch
Stock Analyst at Maxim Group
(1.21)
# 3,636
Out of 4,476 analysts
372
Total ratings
40.1%
Success rate
-0.4%
Average return
Main Sectors:
Stocks Rated by Michael Okunewitch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCWB HCW Biologics | Maintained: Buy | $5 | $4.30 | +16.28% | 24 | Jun 24, 2026 | |
| DFTX Definium Therapeutics | Rated: Buy | $40 → $50 | $44.19 | +13.15% | 15 | Jun 23, 2026 | |
| KPRX Kiora Pharmaceuticals | Maintained: Buy | $12 | $2.62 | +358.00% | 31 | Jun 22, 2026 | |
| VNRX VolitionRx | Initiated Coverage: Buy | $4 | $1.40 | +185.71% | 2 | Jun 18, 2026 | |
| CTOR Citius Oncology | Maintained: Buy | $4 | $0.6804 | +487.89% | 12 | Jun 2, 2026 | |
| MDWD MediWound | Maintained: Buy | $30 | $15.17 | +97.82% | 27 | Jun 1, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $200 | $146.63 | +36.40% | 13 | May 27, 2026 | |
| RANI Rani Therapeutics Holdings | Maintained: Buy | $5 | $0.7713 | +548.26% | 14 | May 21, 2026 | |
| AIDX 20/20 Biolabs | Maintained: Buy | $5 | - | - | 2 | May 21, 2026 | |
| GILD Gilead Sciences | Upgraded: Buy | $165 | $131.27 | +25.70% | 23 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.27 | +120.26% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.72 | +306.98% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.35 | +122.22% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.6905 | - | 24 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.41 | +193.26% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.51 | +429.80% | 22 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8755 | - | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $12 | $2.12 | +466.04% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $0.40 | +150.00% | 23 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $13.62 | -11.89% | 10 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.37 | +243.25% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $5.19 | +92.68% | 19 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.45 | - | 6 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.5746 | - | 28 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.9 | $1.16 | +494.83% | 6 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.36 | n/a | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $0.5601 | n/a | 11 | Sep 13, 2024 |
HCW Biologics
Jun 24, 2026
Maintained: Buy
Price Target: $5
Current: $4.30
Upside: +16.28%
Definium Therapeutics
Jun 23, 2026
Rated: Buy
Price Target: $40 → $50
Current: $44.19
Upside: +13.15%
Kiora Pharmaceuticals
Jun 22, 2026
Maintained: Buy
Price Target: $12
Current: $2.62
Upside: +358.00%
VolitionRx
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
Citius Oncology
Jun 2, 2026
Maintained: Buy
Price Target: $4
Current: $0.6804
Upside: +487.89%
MediWound
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $15.17
Upside: +97.82%
Belite Bio
May 27, 2026
Maintained: Buy
Price Target: $200
Current: $146.63
Upside: +36.40%
Rani Therapeutics Holdings
May 21, 2026
Maintained: Buy
Price Target: $5
Current: $0.7713
Upside: +548.26%
20/20 Biolabs
May 21, 2026
Maintained: Buy
Price Target: $5
Current: -
Upside: -
Gilead Sciences
May 20, 2026
Upgraded: Buy
Price Target: $165
Current: $131.27
Upside: +25.70%
May 18, 2026
Maintained: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
May 18, 2026
Rated: Buy
Price Target: $7
Current: $1.72
Upside: +306.98%
May 14, 2026
Maintained: Buy
Price Target: $3
Current: $1.35
Upside: +122.22%
May 11, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.6905
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $3.41
Upside: +193.26%
May 6, 2026
Maintained: Buy
Price Target: $8
Current: $1.51
Upside: +429.80%
May 4, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.8755
Upside: -
Apr 9, 2026
Rated: Buy
Price Target: $10 → $12
Current: $2.12
Upside: +466.04%
Apr 8, 2026
Maintained: Buy
Price Target: $1
Current: $0.40
Upside: +150.00%
Mar 26, 2026
Maintained: Buy
Price Target: $12
Current: $13.62
Upside: -11.89%
Mar 25, 2026
Maintained: Buy
Price Target: $15
Current: $4.37
Upside: +243.25%
Mar 17, 2026
Rated: Buy
Price Target: $10
Current: $5.19
Upside: +92.68%
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.45
Upside: -
Sep 23, 2025
Maintained: Hold
Price Target: n/a
Current: $0.5746
Upside: -
Sep 13, 2025
Maintained: Hold
Price Target: $6.9
Current: $1.16
Upside: +494.83%
Mar 3, 2025
Maintained: Buy
Price Target: $12
Current: $5.36
Upside: n/a
Sep 13, 2024
Maintained: Buy
Price Target: $12
Current: $0.5601
Upside: n/a